Recovery & Repair · Recovery & Repair peptide (research)
Mechano Growth Factor (MGF)
- Drug class
- Recovery & Repair peptide (research)
- Status
- Compounded (503A)
- Also known as
- mechano growth factor, igf-1ec, igf1 ec, mgf peptide
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Mechano Growth Factor (MGF) is studied for
- Satellite cell activation (research)
- Localized muscle repair (research)
- Short half-life pulse (research)
Mechanism of action
Mechano Growth Factor (MGF) is being studied in the recovery & repair category. IGF-1Ec splice variant released after mechanical loading — studied for muscle repair. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Mechano Growth Factor (MGF)?
Mechano Growth Factor (MGF) is a recovery & repair peptide. IGF-1Ec splice variant released after mechanical loading — studied for muscle repair.
What is Mechano Growth Factor (MGF) studied for?
Published research has examined Mechano Growth Factor (MGF) for satellite cell activation, localized muscle repair, short half-life pulse. Human clinical evidence varies by indication.
Is Mechano Growth Factor (MGF) FDA-approved?
No. Mechano Growth Factor (MGF) is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Mechano Growth Factor (MGF) used in research?
Protocols vary by study. Mechano Growth Factor (MGF) is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Mechano Growth Factor (MGF) is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.